Literature DB >> 26811802

Mortality in individuals with intellectual disabilities in Finland.

Maria Arvio1, Tommi Salokivi2, Aila Tiitinen3, Leena Haataja4.   

Abstract

OBJECTIVES: This study aimed at ascertaining the standardized mortality ratios (SMR) for those with an intellectual disability (ID) in Finland.
MATERIALS AND METHODS: We used the statistical database of the national insurance institution of Finland and Statistics Finland's mean population figures. We determined the number of individuals who received benefits (disability allowance, disability pension, or care allowance for pensioners) due to an ID diagnosis and the number of those whose benefit had been terminated due to death during the years 1996-2011.
RESULTS: SMR for females with a mild ID (IQ 50-69) was 2.8 (95% CI: 2.60-3.01) and for males 2.0 (95% CI: 1.88-2.14), and for females with a severe ID (IQ <50) 5.2 (95% CI: 4.99-5.50) and for males 2.6 (95% CI: 2.48-2.72).
CONCLUSION: This significant difference in the SMR figures between males and females with ID warrants further research.

Entities:  

Keywords:  Gender; intellectual disability; mortality; standardized mortality ratios

Mesh:

Year:  2016        PMID: 26811802      PMCID: PMC4724595          DOI: 10.1002/brb3.431

Source DB:  PubMed          Journal:  Brain Behav            Impact factor:   2.708


Introduction

Those with an intellectual disability (ID) form a heterogenic group. IDs can be classified into subgroups based on their etiology (genetic, acquired or multifactorial), severity, and comorbidities. The most common genetic cause for ID is Down syndrome; the most frequent acquired condition is cerebral palsy‐associated ID, and the most common multifactorial condition is autism spectrum‐related ID syndrome (Arvio et al. 2014). Severe ID almost always associates with such other impairments as speech abnormalities, epilepsy, psychiatric disorders and movement disorder. Many with an ID deteriorate over time due to their underlying neurological conditions which may be progressive in nature (Arvio and Sillanpää 2003). Worldwide, those with an ID, form the largest single disability group. In western countries approximately 0.7% of the population meets the diagnostic criteria of ID (Leonard and Wen 2002; Westerinen et al. 2007; Søndenaa et al. 2010). The proportion of males with an ID is greater than that of females (Westerinen et al. 2007; Yen et al. 2013). Several reasons explain the higher incidence among males. First, their more frequent autism spectrum disorders, and secondly, the fact that X‐chromosomal disorders such as Fragile‐X syndrome present with more severe cognitive symptoms in males. And finally, boys are more likely to experience traumatic brain injury. In general, no gender difference exists in ID severity (Memisevic and Sinanovic 2014). The age distribution of the ID population is skewed toward younger age groups (Yen et al. 2013). In Finland, child neurological teams in public central hospitals are responsible for ID diagnostics, after which the individual receives a referral to one of the 16 regional state‐supported special care district's out‐patient clinics for a treatment, rehabilitation, and service plan. The main criteria for ID have remained unchanged for decades. These include an IQ below 70 in age‐appropriate psychological tests, age‐inappropriate adaptive skills, and clinical manifestation during the developmental period (WHO, 1996). In Finland, the national social insurance institution (KELA) is primarily responsible for supporting those over the age of 15 with an ID by providing each with disability pension and care allowance. Furthermore, the parents of children and adolescents (under age 16) with an ID receive a disability allowance. ICD‐10 was adopted in Finland in 1996, and KELA uses its codes to classify beneficiaries. Therefore, the Finnish population registers provide a unique database for a more detailed examination of mortality rates. This study aimed to ascertain the standardized mortality ratios (SMR) for people with an ID in Finland.

Methods

KELA's statistical database (www.kela.fi/tilastot) provided us with the number of individuals who received benefits (disability allowance, disability pension or care allowance for pensioners) due to an ID diagnosis (ICD 10: F70–79) during the years 1996–2011. The Finnish Population Register Centre delivers data of citizens’ deaths to KELA; the number of whose benefit had been terminated due to death (observed deaths) during this time period came also from KELA. The expected number of deaths was calculated on the basis of gender‐, 5‐year age groups, and calendar‐period‐specific mortality rates in the Finnish population (www.tilastokeskus.fi). The SMR was calculated as the ratio of observed and expected number of deaths. Ninety‐five percent confidence intervals (95% CI) were computed by assuming that the observed number of deaths followed a Poisson distribution.

Results

The SMR of all subjects with a mild ID (IQ 69–50) and a severe ID (IQ <50) during 1996–2011 according chronological age are presented in Table 1. SMR for females with a mild ID was 2.80 (95% CI: 2.60–3.01) and for males 2.01 (95% CI: 1.88–2.14) (P < 0.001), and for females with a severe ID 5.24 (95% CI: 4.99–5.50) and for males 2.59 (95% CI: 2.48–2.72) (P < 0.001) (Table 2). See the figure showing SMRs in calendar‐year periods according to gender and level of ID. Thorough the observation period, the considerable difference between genders in mortality rates in both ID levels remained stable (Fig. 1).
Table 1

The standardized mortality rate (SMR) of subjects with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011 according age

Person yearsNumber of deathSMR (95% CI)a
ObservedExpected
Mild ID1518351698177.02.28 (2.18 to 2.39)
0–141273581.94.21 (1.82 to 8.30)
15–29240064117.52.34 (1.68 to 3.18)
30–443884116358.92.77 (2.36 to 3.23)
45–5954562693266.82.60 (2.41 to 2.80)
≥6021691793398.91.99 (1.85 to 2.13)
Severe ID22715234731019.13.41 (3.30 to 3.52)
0–14332111108.313.26 (10.90 to)
15–294685027931.88.77 (7.77 to 9.87)
30–445701952587.65.99 (5.49 to 5.53)
45–59639411369317.04.32 (4.09 to 4.55)
≥60261311190574.32.07 (1.96 to 2.19)

Standardized mortality rate.

Table 2

The standardized mortality rate (SMR) of women and men with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011 according age

WomenMen
Number of deathSMR (95% CI)a Number of deathSMR (95% CI)a
ObservedExpectedObservedExpected
Mild ID724485.32.80 (2.60 to 3.01)*** 974258.72.01 (1.88 to 2.14)
0–1440.66.33 (1.72 to 16.20)41.33.15 (0.86 to 8.08)
15–29143.34.28 (2.34 to 7.18)* 2714.21.90 (1.25 to 2.76)
30–446014.34.20 (3.21 to 5.41)*** 10344.62.31 (1.89 to 2.80)
45–5927278.73.45 (3.06 to 3.89)*** 421188.12.34 (2.03 to 2.46)
≥60374161.82.31 (2.08 to 2.56)*** 419237.11.77 (1.60 to 1.94)
Severe ID1641313.25.24 (4.99 to 5.50)*** 1832705.92.59 (2.48 to 2.72)
0–14683.221.35 (16.58 to 27.07)*** 425.18.22 (5.92 to 11.11)
15–291306.420.47 (17.10 to 24.31)*** 14925.55.85 (4.95 to 6.87)
30–4424921.311.71 (10.30 to 13.26)*** 27666.44.16 (3.68 to 4.68)
45–5965280.38.12 (7.51 to 8.77)*** 717236.73.03 (2.81 to 3.26)
≥60549202.12.68 (2.46 to 2.92)*** 648174.11.74 (1.61 to 1.88)

Standardized mortality rate.

*P < 0.05, **P < 0.01, ***P < 0.001 between gender.

Figure 1

The standardized mortality rate (95% confidence intervals) of women and men with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011.

The standardized mortality rate (SMR) of subjects with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011 according age Standardized mortality rate. The standardized mortality rate (SMR) of women and men with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011 according age Standardized mortality rate. *P < 0.05, **P < 0.01, ***P < 0.001 between gender. The standardized mortality rate (95% confidence intervals) of women and men with a mild (IQ 50–69) and a severe (Q < 50) intellectual disability (ID) during 1996–2011.

Discussion

Our research confirms a difference in mortality risk between genders in Finland. In western countries men show higher mortality rate than women (http://www.who.int/nmh/publications/ncd_report_chapter1.pdf). Females with a severe ID had a fivefold higher SMR than Finnish females in general while the corresponding difference among males was twofold. The gender difference among those with a mild ID was smaller but also statistically significant. The corresponding SMR figures in non‐Finnish studies representing various ID‐related disability groups among females range from 7 to 17 and among males from 2 to 9 (Tyrer et al. 2007; Mouridsen et al. 2008; Gillberg et al. 2010; Woolfenden et al. 2012). The strength of our data lies in its being registry‐based and consisting of all the individuals living in Finland who during 1996–2011 received a disability pension, disability allowance or care allowance (refundable drug benefits were not included). In some countries, individuals can choose between pension and full care without finances; this not the case in Finland. We assume that few citizens exist or have existed who have an ID and are sufficiently wealthy to live their entire lives without a disability benefit. Furthermore, anyone who earns a living hardly meets the criteria of ID. We therefore assume that the coverage of our study material is convincing. The weakness of our data is the lack of death causes which have not been nationally registered. In Finland alcoholism is the most common cause of death in males and the second most common cause in females under the age of 65 (www.terveyskirjasto.f/xmedia/ldk/). An ID, in itself, almost always makes substance addiction (with the exception of psychopharmacy) impossible, because as those with an ID generally live under supervision and are unable to obtain addictive substances by themselves. Breast cancer is the most common cause of death in females under the age of 65 (www.terveyskirjasto.f/xmedia/ldk/); an ID is not a known risk factor for breast cancer, although being childless is (Raitasuo et al. 1996; Patja et al. 2001; Tyrer and McGrother 2009). Several studies have shown that cardiovascular disease, the second most common cause of death for Finnish males and the fifth for Finnish females (www.terveyskirjasto.f/xmedia/ldk/), is the most common cause of death in those, specifically females, with an ID (Raitasuo et al. 1996; Patja et al. 2001). This indicates that the most important cause of the mortality difference between genders may be cardiovascular mortality. The SMR difference between genders challenges us to further study of why female gender is a risk factor for those with ID suffering premature death, although being male is a risk factor for ID.

Conflict of Interest

None of the authors has any conflict of interest to disclose.
  13 in total

Review 1.  The epidemiology of mental retardation: challenges and opportunities in the new millennium.

Authors:  Helen Leonard; Xingyan Wen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

2.  Executive function in children with intellectual disability--the effects of sex, level and aetiology of intellectual disability.

Authors:  H Memisevic; O Sinanovic
Journal:  J Intellect Disabil Res       Date:  2013-11-11

3.  Cause-specific mortality of people with intellectual disability in a population-based, 35-year follow-up study.

Authors:  K Patja; P Mölsä; M Iivanainen
Journal:  J Intellect Disabil Res       Date:  2001-02

Review 4.  A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality.

Authors:  Sue Woolfenden; Vanessa Sarkozy; Greta Ridley; Michael Coory; Katrina Williams
Journal:  Dev Med Child Neurol       Date:  2012-02-21       Impact factor: 5.449

5.  Mortality in autism: a prospective longitudinal community-based study.

Authors:  Christopher Gillberg; Eva Billstedt; Valter Sundh; I Carina Gillberg
Journal:  J Autism Dev Disord       Date:  2010-03

6.  Cause-specific mortality and death certificate reporting in adults with moderate to profound intellectual disability.

Authors:  F Tyrer; C McGrother
Journal:  J Intellect Disabil Res       Date:  2009-08-18

7.  Mortality and causes of death in autism spectrum disorders: an update.

Authors:  Svend Erik Mouridsen; Henrik Brønnum-Hansen; Bente Rich; Torben Isager
Journal:  Autism       Date:  2008-07

8.  Prevalence, aetiology and comorbidity of severe and profound intellectual disability in Finland.

Authors:  M Arvio; M Sillanpää
Journal:  J Intellect Disabil Res       Date:  2003-02

9.  Mortality in adults with moderate to profound intellectual disability: a population-based study.

Authors:  F Tyrer; L K Smith; C W McGrother
Journal:  J Intellect Disabil Res       Date:  2007-07

10.  Prevalence of intellectual disability: a comprehensive study based on national registers.

Authors:  H Westerinen; M Kaski; L Virta; F Almqvist; M Iivanainen
Journal:  J Intellect Disabil Res       Date:  2007-09
View more
  10 in total

1.  Mortality patterns and risk among older men and women with intellectual disability: a Swedish national retrospective cohort study.

Authors:  Nawi Ng; Eva Flygare Wallén; Gerd Ahlström
Journal:  BMC Geriatr       Date:  2017-11-22       Impact factor: 3.921

2.  Rates, causes, place and predictors of mortality in adults with intellectual disabilities with and without Down syndrome: cohort study with record linkage.

Authors:  Sally-Ann Cooper; Linda Allan; Nicola Greenlaw; Paula McSkimming; Adam Jasilek; Angela Henderson; Colin McCowan; Deborah Kinnear; Craig Melville
Journal:  BMJ Open       Date:  2020-05-17       Impact factor: 2.692

3.  Signs indicating dementia in Down, Williams and Fragile X syndromes.

Authors:  Oili Sauna-Aho; Nina Bjelogrlic-Laakso; Auli Siren; Maria Arvio
Journal:  Mol Genet Genomic Med       Date:  2018-07-03       Impact factor: 2.183

4.  Cognition in adults with Williams syndrome-A 20-year follow-up study.

Authors:  Oili Sauna-Aho; Nina Bjelogrlic-Laakso; Auli Sirén; Virpi Kangasmäki; Maria Arvio
Journal:  Mol Genet Genomic Med       Date:  2019-04-29       Impact factor: 2.183

5.  Establishing a national mortality review programme for people with intellectual disabilities: The experience in England.

Authors:  Pauline Heslop; Victoria Byrne; Rachel Calkin; Kamila Gielnik; Avon Huxor
Journal:  J Intellect Disabil       Date:  2020-11-18

6.  Rates, causes and predictors of all-cause and avoidable mortality in 163 686 children and young people with and without intellectual disabilities: a record linkage national cohort study.

Authors:  Laura Anne Hughes-McCormack; Ewelina Rydzewska; Sally-Ann Cooper; Michael Fleming; Daniel Mackay; Kirsty Dunn; Laura Ward; Filip Sosenko; Fiona Barlow; Jenny Miller; Joseph D Symonds; Bhautesh D Jani; Maria Truesdale; Deborah Cairns; Jill Pell; Angela Henderson; Craig Melville
Journal:  BMJ Open       Date:  2022-09-16       Impact factor: 3.006

7.  Association of Intellectual Disability With All-Cause and Cause-Specific Mortality in Sweden.

Authors:  Tatja Hirvikoski; Marcus Boman; Magnus Tideman; Paul Lichtenstein; Agnieszka Butwicka
Journal:  JAMA Netw Open       Date:  2021-06-01

8.  Mortality in individuals with intellectual disabilities in Finland.

Authors:  Maria Arvio; Tommi Salokivi; Aila Tiitinen; Leena Haataja
Journal:  Brain Behav       Date:  2016-01-24       Impact factor: 2.708

9.  Rates and causes of mortality among children and young people with and without intellectual disabilities in Scotland: a record linkage cohort study of 796 190 school children.

Authors:  Gillian S Smith; Michael Fleming; Deborah Kinnear; Angela Henderson; J P Pell; Craig Melville; Sally-Ann Cooper
Journal:  BMJ Open       Date:  2020-08-09       Impact factor: 2.692

10.  Cancer in deceased adults with intellectual disabilities: English population-based study using linked data from three sources.

Authors:  Pauline Heslop; Adam Cook; Brian Sullivan; Rachel Calkin; Johanna Pollard; Victoria Byrne
Journal:  BMJ Open       Date:  2022-03-24       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.